Obstetric and neonatal outcome in women with epilepsy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20172358Keywords:
Ante epileptics, Congenital malformation, Epilepsy, Women with epilepsyAbstract
Background: Epilepsy is the second most common neurological disorder complicating pregnancy next to migraine. Both mother and fetus stay at risk due to epilepsy and side effects of antiepileptic’s. This retrospective study was conducted to study fetal and maternal outcome in WWE.
Methods: This study was conducted on 55 patients of epilepsy with pregnancy who attended antenatal clinic of our hospital from January 2016 to December 2016. Data was collected using antenatal registers in outdoor settings and medical case sheets in indoor patients and was analyzed statistically.
Results: There were a total of 55 WWE in one year duration. Incidence of epilepsy being 0.4% in this study. 11 WWE were not on ante epileptic drug when conceived, while 34 WWE were on ante epileptic drugs when conceived, 8 WWE were newly diagnosed and 2 patients had both psychiatric disorders along with epilepsy. There were 3 IUDs, 4 major congenital malformation and 2 minor malformations. 2 major malformation occurred in patients taking both antipsychotic and ante epileptics since conception.
Conclusions: There were a total of 55 WWE in one year duration. Incidence of epilepsy being 0.4% in this study. 11 WWE were not on ante epileptic drug when conceived, while 34 WWE were on ante epileptic drugs when conceived, 8 WWE were newly diagnosed and 2 patients had both psychiatric disorders along with epilepsy. There were 3 IUDs, 4 major congenital malformation and 2 minor malformations. 2 major malformation occurred in patients taking both antipsychotic and ante epileptics since conception.
References
Chattopadhyay N, Mukherjee A, Pati S, Mukhopadhyay P, Gupta D, Ganguly G. Feto-maternal outcome in pregnancy with epilepsy in a tertiary care hospital. J Obstet Gynecol India. 2008;58:406-9.
EURAP Study Group. Seizure control and treatment in pregnancy. Observations from the EURAP epilepsy pregnancy registry. Neurol. 2006;66:354-60.
Thomas SV, Devi CC, Radhakrishnan K, Joshua CS. Seizure pattern during pregnancy and purperium among women with epilepsy. Epilepsia. 2000;41:198-9.
Artama M, Ritvanen A, Gissler M, Isojarvi J, Auvinen A. Congenital structural anomalies in offspring of women with epilepsy-a population- based cohort study in Finland. Int J Epidemiol. 2006;35:280-7.
Royal College of Obstetricians and Gynaecologists. Epilepsy in pregnancy. Green- top guideline No.68. June 2016.
Thomas SV. Managing epilepsy in pregnancy. Neurol India. 2011;59:59-65.
Thomas SV, Devi CC, Radhakrishnan K, Joshua CS. Seizure pattern during pregnancy and puerperium among women with epilepsy. Epilepsia. 2000;41:198-9.
Saleh AM, Abotalib ZM, Al-Ibrahim AA, Al-Sultan SM. Comparison of maternal and fetal outcomes, in epileptic and non-epileptic women. Saudi Med J. 2008;29:261-6.
Thomas SV, Sindhu K, Ajaykumar B, Sulekha Devi PB, Sujamol J. Maternal and obstetric outcome of women with epilepsy. Seizure. 2009;18:163-6.
Pilo C, Wide K, Winbladh B. Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs. Acta Obstet Gynecol Scand 2006;85:643-6.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, et al. EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10:609-17.
Morrel MJ. Epilepsy in women. Am Fam Physician. 2002;66:1489-94.
Nathan J. Women with epilepsy. J Obstet Gynecol India. 2004;54:543-53.
Morel MJ. Epilepsy and pregnancy: minimizing the risks. Contemp Obstet Gynecol. 2004:49:51-70.
